- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/723 - Xanthans
Patent holdings for IPC class A61K 31/723
Total number of patents in this class: 66
10-year publication summary
8
|
5
|
3
|
1
|
4
|
5
|
2
|
3
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
InovoBiologic Inc. | 147 |
12 |
CP Kelco U.S., Inc. | 144 |
3 |
Shandong Academy of Pharmaceutical Sciences | 15 |
3 |
Biomedical Concepts LLC | 3 |
2 |
Dutch Renewable Energy B.V. | 18 |
2 |
N.V. Nutricia | 1052 |
2 |
United Pharmaceuticals | 7 |
2 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1350 |
2 |
Shandong Freda Pharmaceutical Group Co., Ltd. | 6 |
2 |
Lyotropic Delivery Systems Ltd. | 14 |
2 |
Société des Produits Nestlé S.A. | 9154 |
1 |
Unilever PLC | 3244 |
1 |
Unilever N.V. | 3145 |
1 |
Conopco, Inc. | 4930 |
1 |
Nestec S.A. | 2684 |
1 |
Colgate-Palmolive Company | 5764 |
1 |
Ajinomoto Co., Inc. | 2301 |
1 |
Abbott Healthcare Private Limited | 20 |
1 |
Asahi Group Holdings, Ltd. | 431 |
1 |
Ceradis B.V. | 35 |
1 |
Other owners | 24 |